Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival-Reference-Cited by-同舟云学术

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

Published:2010-01 Issue:1 Volume:11 Page:21-28
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Bonner James A,Harari Paul M,Giralt Jordi,Cohen Roger B,Jones Christopher U,Sur Ranjan K,Raben David,Baselga Jose,Spencer Sharon A,Zhu Junming,Youssoufian Hagop,Rowinsky Eric K,Ang K Kian

Publisher

Elsevier BV

Subject

Oncology

Reference41 articles.

1. The evaluation of treatment of patients with extensive squamous cancer of the vocal cords;Jesse;Laryngoscope,1975

2. Preoperative x-ray therapy as an adjunct to radical neck dissection;Strong;Cancer,1966

3. Accelerated fractionation in the radiation treatment of head and neck cancer;Peters;Acta Oncol,1988

4. Pre-operative irradiation in the treatment of advanced laryngeal carcinoma;Bryce;Laryngoscope,1971

5. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer;N Engl J Med,1991

Cited by 1696 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment De-escalation in Oropharyngeal Carcinoma and the Role of Robotic Surgery;Surgical Oncology Clinics of North America;2024-10

2. FGD-PET/CT three months after (chemo)radiotherapy for head and neck squamous cell carcinoma spares considerable number of patients from a salvage neck dissection;Radiotherapy and Oncology;2024-09

3. Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline;Practical Radiation Oncology;2024-09

4. Primary cilia-associated signalling in squamous cell carcinoma of head and neck region;Frontiers in Oncology;2024-08-21

5. Expression of p16INK4a, FLOT2, and EGFR in oropharyngeal carcinoma, prognostic significance and correlation with clinicopathological characteristics;Medicine;2024-08-16